Nitrofurantoin Oral Suspension
Brand names: Nitrofurantoin
Category: Anti-Infective, Other
FDA status: To Be Discontinued · Last FDA update: Apr 10, 2026 · First posted: Apr 10, 2026 · 1 manufacturers, 1 listed presentations
As of Apr 10, 2026, the FDA lists Nitrofurantoin Oral Suspension as being discontinued. Of 1 manufacturer presentations, 1 Not specified.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Nitrofurantoin, Oral Suspension, 25 mg/5 mL (NDC 69238-2512-9) NDC 69238-2512-9 |
Amneal Pharmaceuticals | Not specified | Discontinuation of the manufacture of the drug |
Related medications in shortage
Other Anti-Infective, Other medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Nitrofurantoin Oral Suspension (FDA data as of Apr 10, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Nitrofurantoin Oral Suspension. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/nitrofurantoin-oral-suspension.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).